Search the Newsreel

Alkem Laboratories Q1 results: Net profit drops 21% YoY; board approves setting up new block at Baddi plant

Assenagon Asset Management S.A. Sells 18,417 Shares of BorgWarner Inc. $BWA

Assenagon Asset Management S.A. has reduced its stake in BorgWarner Inc. (NYSE:BWA) by 28.6%, selling 18,417 shares and retaining 45,887 shares valued at $3.05 million. BorgWarner recently exceeded quarterly expectations with $1.42 adjusted EPS and $3.65 billion in revenue, also announcing a $1 billion …

Clean Harbors, Inc. $CLH Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB reduced its stake in Clean Harbors, Inc. (NYSE:CLH) by 29.8% in the second quarter, selling 27,815 shares and retaining 65,529 shares. Despite this sale, institutional investors collectively own 90.43% of the company. Clean Harbors continues to receive favorable analyst ratings, with …

Silicon Laboratories, Inc. (NASDAQ:SLAB) Given Average Rating of "Reduce" by Brokerages

Silicon Laboratories, Inc. (NASDAQ:SLAB) has received an average "Reduce" rating from six brokerages, with an average 12-month price target of $218. The company recently reported quarterly adjusted EPS of $0.71 on revenue of $228.19 million, surpassing analyst expectations. Despite insider selling by the CEO, …

IDEXX Laboratories Inc (IDXX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of IDEXX Laboratories Inc (IDXX), focusing on its current price momentum, support and resistance levels, and various technical indicators and moving averages. The stock has a momentum score of 3.37, trading between a resistance of 605.29 and support …

Borr Drilling Limited - Notification of PDMR Transactions

Borr Drilling Limited announced that two Persons Discharging Managerial Responsibilities (PDMRs) have purchased company shares. Drew Holdings Ltd., a close associate of director Tor Olav Trøim, bought 1,500,000 shares for approximately $4.0245 each, and director Jeffrey Currie purchased 125,000 shares at about $4.0131 each. …

5 Insightful Analyst Questions From Charles River Laboratories’s Q2 Earnings Call

5 Insightful Analyst Questions From Charles River Laboratories's Q2 Earnings Call Charles River Laboratories' second quarter results were shaped by recovering biopharmaceutical demand and the impact of portfolio streamlining. Management highlighted that the rebound was most evident in the Discovery and Safety Assessment (DSA) …

Ipca Laboratories shares fall over 2%; strong financial performance reported

Neuland Lab Consolidated June 2026 Net Sales at Rs 641.58 crore, up 119.15% Y-o-Y

Brooks Laboratories reports consolidated net loss of Rs 1.79 crore in the June 2026 quarter

Top Abbott Executive Makes Bold Move With Fresh Insider Stock Sale

An executive at Abbott Laboratories (ABT), Louis H. Morrone, recently sold 5,850 shares of company stock for $642,505. This insider transaction provides investors with additional data to consider regarding the company's current valuation. Abbott's stock performance and analyst ratings are influenced by its strong …

Grove (GROV) Q2 2026 Earnings Call Transcript

Could Danaher Corporation (DHR)’s Bioprocessing Recovery Give Bio-Rad Laboratories (BIO) Stock a Boost?

When biopharmaceutical suppliers report earnings, ripples move fast across the sector. On July 21, Danaher Corporation (NYSE:DHR) reported its Q2 2026 results. While the life sciences giant continues to lead in financial scale, its bioprocessing unit missed expectations, signaling continued softness in broader biopharma …

ArborGen Sets September Date for 2026 Annual Shareholders’ Meeting

Borr Drilling (BORR) Stock Can Backlog Growth Outrun A Deepening Loss?

Borr Drilling's stock has declined despite a low P/S multiple and bullish long-range forecasts, as its Q2 2026 net loss widened significantly to US$241.4m due to refinancing and rig transition costs. While contract coverage for 2026 remains strong, supporting the bullish narrative, the deepened …

Birgit Girshick Sells 6,500 Shares of Charles River Laboratories International (NYSE:CRL) Stock

Birgit Girshick, CEO of Charles River Laboratories International (NYSE:CRL), sold 6,500 shares of the company's stock for approximately $1.82 million. This transaction, executed under a Rule 10b5-1 trading plan, reduced her ownership by 15.29%. The company recently reported strong quarterly EPS and revenue that …

Charles River Laboratories International (NYSE:CRL) EVP Sells $1,038,657.24 in Stock

Charles River Laboratories International's EVP, Shannon Parisotto, sold 3,714 shares of company stock for approximately $1.04 million, reducing her holdings by 43.59%. This transaction was conducted under a pre-arranged Rule 10b5-1 plan. The company recently reported adjusted earnings of $3.02 per share, exceeding estimates, …

Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors

Charles River Laboratories International Inc. (CRL) stock fell 1.09% to $281.27 on Thursday, despite a positive trading session for the broader market. This underperformance snapped a seven-day winning streak for the company's shares. The S&P 500 Index rose 0.65%, and the Dow Jones Industrial …

Charles River Labs (CRL) CEO exercises 6,500 options and sells shares under 10b5-1 plan

Charles River Laboratories (CRL) CEO Birgit Girshick exercised stock options for 6,500 shares on August 11, 2026, at an exercise price of $179.66 per share. Simultaneously, she sold these 6,500 common shares at $279.90 per share. These transactions were conducted under a pre-arranged Rule …

Charles River (CRL) executive Parisotto exercises options, sells 3,714 shares under 10b5-1 plan

Shannon M. Parisotto, CEVP, Discovery & Safety Assessment at Charles River Laboratories International, exercised stock options for 3,714 shares at $179.66 per share and simultaneously sold the same number of shares at $279.66 per share. These transactions, executed on August 11, 2026, were conducted …

Invesco reports 2.98M-share stake in Charles River Laboratories (CRL)

Invesco Ltd., a Bermuda-based parent holding company, has reported a significant passive ownership position in Charles River Laboratories International, Inc. (CRL) common stock. The firm beneficially owns 2,984,785 shares, representing 6.2% of the outstanding common stock, held by its investment advisory clients. Invesco maintains …

Mesa Laboratories (NASDAQ:MLAB) Hits New 12-Month High - Here's Why

BorgWarner Inc. stock underperforms Thursday when compared to competitors

BorgWarner Inc. (BWA) stock fell 1.42% on Thursday, closing at $67.87, despite a strong performance by the broader stock market, with the S&P 500 Index and Dow Jones Industrial Average both rising. This marks the second consecutive day of losses for the company's stock.

Silicon Labs Q2 FY 2026: IoT Recovery Builds Momentum for Series 3 Platform

Silicon Labs reported strong Q2 FY 2026 earnings, showing sequential improvements in revenue, gross margin, and profitability, indicating a recovery in the IoT semiconductor sector. The company's new 22nm Series 3 platform is central to its strategy of moving into more complex, compute-heavy, and …

Strategic Growth: Clean Harbors adds 40 U.S. locations through $470M EnviroServe deal

Clean Harbors Inc. is set to acquire EnviroServe for $470 million in cash, a move that will add 40 U.S. locations and significantly expand Clean Harbors' environmental and industrial services. This strategic acquisition will strengthen its Technical Services business, enhance its disposal and recycling …

Core Laboratories (NYSE:CLB) Stock Rating Upgraded by Johnson Rice

Johnson Rice upgraded Core Laboratories (NYSE:CLB) from a "hold" to a "buy" rating, setting a $21.00 price target. This upgrade implies a significant upside, although the broader analyst consensus remains "Hold." The company recently reported better-than-expected EPS but missed revenue estimates, while its CEO …

Borr Drilling Ltd (BORR) CFO details extensive option awards and share stake

Borr Drilling Ltd's CFO, Magnus Vaaler, has reported his equity holdings, which consist of employee stock options and direct common share ownership. The options have exercise prices ranging from $1.66 to $6.54 and expiration dates between 2026 and 2029, with vesting tied to continued …

Borr Drilling Ltd (BORR) CAO details 68,729 shares and multiple option grants

Borr Drilling Ltd's Chief Accounting Officer, Jehan Mawjee, reported current equity holdings including 68,729 common shares and multiple employee stock options. The filing indicates no new purchases or sales, but details restricted stock units (RSUs) vesting between 2026 and 2028 and options with exercise …

Dr. Reddy’s Laboratories (RDY) CEO API & Services Deepak Sapra resigns effective November 12, 2026

Dr. Reddy’s Laboratories announced that Deepak Sapra, CEO of API & Services and a Senior Management Personnel, has resigned to pursue outside opportunities. His resignation is effective November 12, 2026, and he will remain with the company until then to ensure a smooth transition …

Silicon Labs: Medical Revenue Surges 78% To Record As IoT Design Wins Accelerate

Silicon Labs reported a record 78% year-over-year increase in Medical revenue for Q2, driven by accelerating IoT design wins and stronger demand across its portfolio. Total Q2 revenue rose 18% to $228 million, with significant growth in Industrial & Commercial and Home & Life …

Borr Drilling (NYSE: BORR) swings to $241M Q2 loss after major refinancing

Borr Drilling (NYSE: BORR) reported a significant Q2 2026 net loss of $241.4 million, a sharp increase from $29.0 million in Q1 2026, despite revenues of $232.3 million. This loss followed a major refinancing effort where the company issued $2.035 billion in new senior …

Stocks in play: Xanadu Quantum Technologies Limited

Xanadu Quantum Technologies Limited has announced a strategic research partnership with the University of Alberta to develop novel quantum algorithms for cancer treatment. This collaboration aims to accelerate the design of next-generation photosensitizers used in photodynamic therapy. Following this announcement, shares of Xanadu Quantum …

Abbott Laboratories (NYSE:ABT) Raised to Outperform at Wolfe Research

Wolfe Research upgraded Abbott Laboratories (NYSE:ABT) to "outperform" from "peer perform," setting a $130 price target, which suggests a 17.2% upside. This upgrade comes after Abbott's recent quarterly results surpassed expectations, with EPS of $1.31 and revenue of $12.59 billion, an increase of 13% …

What's Backing Abbott's Established Pharmaceuticals Division Growth

Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …

Arbor Realty Trust's Dip Creates Large But Uncovered 12% Dividend Yield (NYSE:ABR)

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday. Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption. He said the June quarter …